No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ATRI Atrion
- 451.250
- -21.150-4.48%
Close May 21 16:00 ET
794.18MMarket Cap42.45P/E (TTM)
473.000High450.000Low40.64KVolume473.000Open472.400Pre Close18.69MTurnover3.04%Turnover Ratio40.95P/E (Static)1.76MShares592.05152wk High3.28P/B602.53MFloat Cap271.53252wk Low8.75Dividend TTM1.34MShs Float887.894Historical High1.94%Div YieldTTM4.87%Amplitude4.348Historical Low459.950Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Atrion Keeps Quarterly Cash Dividend at $2.20 a Share, Payable June 28 to Holders of Record June 14
04:53 PM EDT, 05/21/2024 (MT Newswires) -- Atrion Keeps Quarterly Cash Dividend at $2.20 a Share, Payable June 28 to Holders of Record June 14
Press Release: Atrion Corporation Declares Quarterly Cash Dividend
Atrion Corporation Declares Quarterly Cash Dividend ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly d
Atrion Corporation's (NASDAQ:ATRI) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Atrion (NASDAQ:ATRI) has had a great run on the share market with its stock up by a significant 17% over the last three months. But the company's key financial indicators appear to be differing acro
Atrion | 10-Q: Quarterly report
Express News | Atrion Q1 2024 EPS $1.59 Down From $1.98 YoY; Revenue $47.334M Up From $39.003M YoY
Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $47.3M
04:10 PM EDT, 05/10/2024 (MT Newswires) -- Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $47.3M
Comments
Atrion's declining ROCE and constant capital employed suggest it may be past its growth phase. Lower returns from the same capital are not signs of a compounding machine, suggesting the market may not favor these trends.
Atrion (NASDAQ:ATRI) Has Some Difficulty Using Its Capital Effectively 1
Despite Atrion's recent share price increase, market confidence remains low due to poor long-term performance. However, significant insider buying last quarter is seen positively. The company's 5-year TSR, exceeding share price return, is largely due to dividends.
Atrion's high P/E ratio, despite earnings slump, signifies strong investor optimism. This could lead to future letdown if P/E aligns with recent negative growth. The stock appears risky, particularly considering the medium-term earnings trends.
Atrion's diminishing ROCE trend indicates it might be a mature business faced with new competition or shrinking margins, resulting in lower returns despite viable areas for capital usage. A continuation of this pattern could hinder high earnings for Atrion.
Hi there, I saw this stock ATRI down quite a bit lately but their balance sheet looks pretty solid and their revenues and profits seem to be holding up. The company sells medical products for fluid delivery, cardiovascular and ophthalmology markets. Does anyone own or have this stock on their watchlist and know much about the company and why the price is falling so rapidly? $Atrion(ATRI.US$
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg